FDA Commissioner Defends Zohydro Despite Abuse Potential (FREE)

By Joe Elia The FDA commissioner is defending the agency's decision to keep Zohydro ER — an extended-release formulation of hydrocodone — on the market despite warnings …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news